跳至主要内容
临床试验/2023-505500-37-00
2023-505500-37-00招募中3 期

Echec-MAT - A combination of antibiotics to improve neonatal mortality and morbidity for pregnancies complicated with previable labour and intact membranes: an open multiple center, randomized, and controlled trial

Assistance Publique Hopitaux De Paris9 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2024年9月19日最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
350
试验地点
9
主要终点
Composite criterion combining late miscarriage, perinatal mortality, and/or severe neonatal morbidity occurring before hospital discharge, including: 1-Late miscarriage

研究概览

简要总结

Reduce neonatal mortality and severe morbidity by prolonging pregnancies complicated by the threat of late miscarriage with intact membranes

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
性别
Female
接受健康志愿者

入选标准

  • Threat of late miscarriage with intact membranes between 18 0/7 and 23 6/7 weeks of gestation, defined by transvaginal ultrasound as a cervix ≤10 mm, and/or protrusion of the amniotic sac observed with a speculum.
  • Singleton pregnancy
  • Living fetus at the time of inclusion
  • Maternal age >18 years
  • Absence of regular and painful uterine contractions
  • Adequate understanding of the French language
  • Affiliated with social security

排除标准

  • Preterm labor defined by regular and painful uterine contractions, and a short cervix
  • Patient under state medical aid (AME) if not exempted from the affiliation requirement
  • Protected person (patient under guardianship/curatorship/legal protection)
  • Multiple pregnancies
  • Premature rupture of membranes
  • Acute chorioamnionitis
  • Contraindication to the antibiotics in the protocol
  • Chromosomal anomaly, congenital malformation
  • Patients who have received antibiotics before inclusion or who require antibiotics for another indication (chorioamnionitis, pyelonephritis, etc.)
  • Participation in another interventional research study or being in the exclusion period following a previous study involving human subjects, if applicable

结局指标

主要结局

Composite criterion combining late miscarriage, perinatal mortality, and/or severe neonatal morbidity occurring before hospital discharge, including: 1-Late miscarriage

Composite criterion combining late miscarriage, perinatal mortality, and/or severe neonatal morbidity occurring before hospital discharge, including: 1-Late miscarriage

Perinatal mortality

Perinatal mortality

Bronchopulmonary dysplasia

Bronchopulmonary dysplasia

Sepsis proven by blood culture

Sepsis proven by blood culture

Intraventricular hemorrhage ≥ Grade 3

Intraventricular hemorrhage ≥ Grade 3

Periventricular leukomalacia ≥ Grade 2

Periventricular leukomalacia ≥ Grade 2

Necrotizing enterocolitis at stage ≥ 2 according to Bell's classification

Necrotizing enterocolitis at stage ≥ 2 according to Bell's classification

次要结局

  • Each item of the composite criterion: 1-Neonatal mortality and late miscarriage
  • Bronchopulmonary dysplasia according to international recommendations (described by Jobe and Bancalari), diagnosed at discharge or at a corrected age of 36 6/7 weeks of gestation.
  • Sepsis proven by culture, diagnosed by a combination of clinical signs and a positive blood culture
  • Intraventricular hemorrhage ≥ Grade 3 and/or periventricular leukomalacia, diagnosed by repeated transfontanellar ultrasounds (according to the classification of Vries and Ment)
  • Necrotizing enterocolitis ≥ Stage 2, using Bell's classification.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

coordinating investigator

Scientific

Assistance Publique Hopitaux De Paris

研究点 (9)

Loading locations...

相似试验